Octreotide Treatment of Chylothorax in Pediatric Patients following Cardiothoracic Surgery

Abstract

Octreotide treatment of chylothorax in combination with dietary modifications in pediatric patients following cardiothoracic surgery resulted in a reduction of peak effusion drainage and eventual resolution in the majority of cases with few and transient side effects.